Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy

PURPOSE: To report the visual and anatomical outcomes of intravitreal ziv-aflibercept (IVZ) and bevacizumab (BVZ) monotherapy in treatment-naive polypoidal choroidal vasculopathy (PCV). METHODS: This was a retrospective case series of 16 eyes (8 eyes each in IVZ and BVZ groups). The study period was...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Indian J Ophthalmol
Autores principales: Singh, Sumit Randhir, Sahoo, Niroj Kumar, Goud, Nallamasa Rohit, Chhablani, Jay
Formato: Artigo
Lenguaje:Inglês
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6611246/
https://ncbi.nlm.nih.gov/pubmed/31238423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijo.IJO_638_18
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares